Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 11 (2024)

Severity of native pulmonary annular hypoplasia and late outcomes of tetralogy of Fallot: retrospective cohort study

DOI
https://doi.org/10.57187/s.3689
Cite this as:
Swiss Med Wkly. 2024;154:3689
Published
01.11.2024

Summary

OBJECTIVE: Pulmonary annular hypoplasia and valvar dysplasia are key morphological features affecting long-term outcomes of tetralogy of Fallot. This retrospective study aimed to analyse factors affecting contemporary long-term outcomes with a focus on pulmonary annular growth and function over time.

METHODS: 131 consecutive isolated tetralogy of Fallot repairs performed between 2004 and 2014 at University Children’s Hospital Zurich were included. Median age and weight at the time of repair were 4.8 (interquartile range [IQR] 3.2–6.3) months and 6.1 (IQR 5.1–7) kg, respectively. Based on the severity of native pulmonary annular hypoplasia, the cohort was divided into group 1 (preoperative pulmonary annular Z score < –4; n = 20), group 2 (Z score –2 to –4; n = 56) and group 3 (Z score > –2; n = 54). A transannular patch was used in 88/131 (67.2%) patients: 80%, 67.9% and 61.1% in groups 1, 2 and 3, respectively. The primary outcome was defined as right ventricular outflow tract (RVOT) reoperation or pulmonary valve replacement. Secondary outcome was composite pulmonary valve dysfunction defined as peak gradient >40 mm Hg or severe pulmonary regurgitation at follow-up. A multiple Cox regression model was used to quantify the association of age at tetralogy of Fallot repair, preoperative pulmonary annular Z score and RVOT approach with primary and secondary outcome. Follow-up was 98.5% complete, with a median follow-up duration of 9.6 (95% confidence interval [CI] 9–10.4) years.

RESULTS: All patients were alive at last follow-up resulting in 100% survival. 20/131 patients underwent pulmonary valve replacement (14 surgical and 6 catheter interventional) while 5/131 underwent RVOT reoperations other than valve replacement. The Kaplan-Meier 10-year freedom from primary outcome was 85% (95% CI 78–92%); 69% (46–100%), 91% (82–100%) and 84% (74–95%) for groups 1, 2 and 3, respectively (log rank p = 0.16). Composite dysfunction at follow-up was observed in 29.8% (overall): 45%, 28.6% and 25.9% for groups 1, 2 and 3, respectively (p = 0.12). The multiple Cox regression analysis for primary outcome indicated that the use of a transannular patch results in a Hazard Ratio (HR) of 3.3 (95% CI 0.7–14.7, p = 0.13). Additionally, the presence of composite dysfunction at discharge results in a HR of 2.1 (95% CI 0.8–5.4, p = 0.1). Age (in months) with a HR of 0.8 (95% CI 0.6–1, p = 0.06) and group 2 with a HR of 0.4 (95% CI 0.14–1.2, p = 0.11) showed a trend to being protective for the primary outcome. However, the 95% CI of all estimates included the HR of 1.

CONCLUSIONS: Transannular patch use and composite dysfunction at discharge, although not statistically significant at 5% level, may be associated with pulmonary valve replacement and RVOT reoperation. Avoiding the use of a transannular patch or using reconstructive techniques to achieve a better composite dysfunction at discharge could reduce the primary outcome. Large multicentre studies are needed to demonstrate more precisely the impact of pulmonary annulus Z scores on outcome.

References

  1. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol. 2005 Jul;46(1):1–8. doi: https://doi.org/10.1016/j.jacc.2005.02.083 DOI: https://doi.org/10.1016/j.jacc.2005.02.083
  2. Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997 Nov;30(5):1374–83. doi: https://doi.org/10.1016/S0735-1097(97)00318-5 DOI: https://doi.org/10.1016/S0735-1097(97)00318-5
  3. Cuypers JA, Menting ME, Konings EE, Opić P, Utens EM, Helbing WA, et al. Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction. Circulation. 2014 Nov;130(22):1944–53. doi: https://doi.org/10.1161/CIRCULATIONAHA.114.009454 DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.009454
  4. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Evans SP, Gatzoulis M, et al. Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort. Pediatr Cardiol. 2013 Jan;34(1):95–104. doi: https://doi.org/10.1007/s00246-012-0394-5 DOI: https://doi.org/10.1007/s00246-012-0394-5
  5. Turrentine MW, McCarthy RP, Vijay P, McConnell KW, Brown JW. PTFE monocusp valve reconstruction of the right ventricular outflow tract. Ann Thorac Surg. 2002 Mar;73(3):871–9. doi: https://doi.org/10.1016/S0003-4975(01)03441-5 DOI: https://doi.org/10.1016/S0003-4975(01)03441-5
  6. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late? J Am Coll Cardiol. 2000 Nov;36(5):1670–5. doi: https://doi.org/10.1016/S0735-1097(00)00930-X DOI: https://doi.org/10.1016/S0735-1097(00)00930-X
  7. Geva T. Tetralogy of Fallot repair: ready for a new paradigm. J Thorac Cardiovasc Surg. 2012 Jun;143(6):1305–6. doi: https://doi.org/10.1016/j.jtcvs.2012.01.076 DOI: https://doi.org/10.1016/j.jtcvs.2012.01.076
  8. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995 Jul;92(2):231–7. doi: https://doi.org/10.1161/01.CIR.92.2.231 DOI: https://doi.org/10.1161/01.CIR.92.2.231
  9. Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr. 2008 Aug;21(8):922–34. doi: https://doi.org/10.1016/j.echo.2008.02.006 DOI: https://doi.org/10.1016/j.echo.2008.02.006
  10. Welch BL. On the Comparison of Several Mean Values - an Alternative Approach. Biometrika. 1951;38(3-4):330–6. doi: https://doi.org/10.1093/biomet/38.3-4.330 DOI: https://doi.org/10.1093/biomet/38.3-4.330
  11. Grambsch PM, Therneau TM. Proportional Hazards Tests and Diagnostics Based on Weighted Residuals. Biometrika. 1994;81(3):515–26. doi: https://doi.org/10.1093/biomet/81.3.515 DOI: https://doi.org/10.1093/biomet/81.3.515
  12. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005 Mar;95(6):779–82. doi: https://doi.org/10.1016/j.amjcard.2004.11.037 DOI: https://doi.org/10.1016/j.amjcard.2004.11.037
  13. Rao V, Kadletz M, Hornberger LK, Freedom RM, Black MD. Preservation of the pulmonary valve complex in tetralogy of fallot: how small is too small? Ann Thorac Surg. 2000 Jan;69(1):176–9. doi: https://doi.org/10.1016/S0003-4975(99)01152-2 DOI: https://doi.org/10.1016/S0003-4975(99)01152-2
  14. Kim DH, Lee JH, Choi ES, Park CS, Yun TJ. Optimal Pulmonary Valve Annulus Diameter for Annulus Preservation in Tetralogy of Fallot May Be Far Smaller Than Normal Annulus Size. Semin Thorac Cardiovasc Surg. 2019;31(2):253–63. doi: https://doi.org/10.1053/j.semtcvs.2018.10.014 DOI: https://doi.org/10.1053/j.semtcvs.2018.10.014
  15. Geva T. Diffuse Myocardial Fibrosis in Repaired Tetralogy of Fallot: Linking Pathophysiology and Clinical Outcomes. Circ Cardiovasc Imaging. 2017 Mar;10(3):e006184. doi: https://doi.org/10.1161/CIRCIMAGING.117.006184 DOI: https://doi.org/10.1161/CIRCIMAGING.117.006184
  16. Yim D, Riesenkampff E, Caro-Dominguez P, Yoo SJ, Seed M, Grosse-Wortmann L. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot. Circ Cardiovasc Imaging. 2017 Mar;10(3):e005695. doi: https://doi.org/10.1161/CIRCIMAGING.116.005695 DOI: https://doi.org/10.1161/CIRCIMAGING.116.005695
  17. Awori MN, Mehta NP, Mitema FO, Kebba N. Optimal Use of Z-Scores to Preserve the Pulmonary Valve Annulus During Repair of Tetralogy of Fallot. World J Pediatr Congenit Heart Surg. 2018 May;9(3):285–8. doi: https://doi.org/10.1177/2150135118757991 DOI: https://doi.org/10.1177/2150135118757991
  18. Hoashi T, Kagisaki K, Meng Y, Sakaguchi H, Kurosaki K, Shiraishi I et al. Long-term outcomes after definitive repair for tetralogy of Fallot with preservation of the pulmonary valve annulus. J Thorac Cardiovasc Surg 2014;148:802-8; discussion 08-9. DOI: https://doi.org/10.1016/j.jtcvs.2014.06.008
  19. Stewart RD, Backer CL, Young L, Mavroudis C. Tetralogy of Fallot: results of a pulmonary valve-sparing strategy. Ann Thorac Surg. 2005 Oct;80(4):1431–8. doi: https://doi.org/10.1016/j.athoracsur.2005.04.016 DOI: https://doi.org/10.1016/j.athoracsur.2005.04.016
  20. van den Bosch E, Bogers AJ, Roos-Hesselink JW, van Dijk AP, van Wijngaarden MH, Boersma E, et al. Long-term follow-up after transatrial-transpulmonary repair of tetralogy of Fallot: influence of timing on outcome. Eur J Cardiothorac Surg. 2020 Apr;57(4):635–43. doi: https://doi.org/10.1093/ejcts/ezz331 DOI: https://doi.org/10.1093/ejcts/ezz331
  21. Gerling C, Rukosujew A, Kehl HG, Tjan TD, Hoffmeier A, Vogt J, et al. Do the age of patients with tetralogy of fallot at the time of surgery and the applied surgical technique influence the reoperation rate? a single-center experience. Herz. 2009 Mar;34(2):155–60. doi: https://doi.org/10.1007/s00059-009-3169-x DOI: https://doi.org/10.1007/s00059-009-3169-x
  22. Sinha R, Gooty V, Jang S, Dodge-Khatami A, Salazar J. Validity of Pulmonary Valve Z-Scores in Predicting Valve-Sparing Tetralogy Repairs-Systematic Review. Children (Basel). 2019 May;6(5):67. doi: https://doi.org/10.3390/children6050067 DOI: https://doi.org/10.3390/children6050067
  23. Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, et al. Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2001 Jul;122(1):154–61. doi: https://doi.org/10.1067/mtc.2001.115156 DOI: https://doi.org/10.1067/mtc.2001.115156
  24. Ylitalo P, Nieminen H, Pitkänen OM, Jokinen E, Sairanen H. Need of transannular patch in tetralogy of Fallot surgery carries a higher risk of reoperation but has no impact on late survival: results of Fallot repair in Finland. Eur J Cardiothorac Surg. 2015 Jul;48(1):91–7. doi: https://doi.org/10.1093/ejcts/ezu401 DOI: https://doi.org/10.1093/ejcts/ezu401
  25. Vida VL, Angelini A, Guariento A, Frescura C, Fedrigo M, Padalino M, et al. Preserving the pulmonary valve during early repair of tetralogy of Fallot: anatomic substrates and surgical strategies. J Thorac Cardiovasc Surg. 2015 May;149(5):1358–63.e1. doi: https://doi.org/10.1016/j.jtcvs.2015.01.030 DOI: https://doi.org/10.1016/j.jtcvs.2015.01.030
  26. Logoteta J, Dullin L, Hansen JH, Rickers C, Salehi Ravesh M, Al Bulushi A, et al. Restrictive enlargement of the pulmonary annulus at repair of tetralogy of Fallot: a comparative 10-year follow-up study. Eur J Cardiothorac Surg. 2017 Dec;52(6):1149–54. doi: https://doi.org/10.1093/ejcts/ezx143 DOI: https://doi.org/10.1093/ejcts/ezx143
  27. Bacha EA. Increased Reinterventions After Valve-Sparing Tetralogy of Fallot Repair: Is It the Price to Pay? Semin Thorac Cardiovasc Surg. 2019;31(2):264–5. doi: https://doi.org/10.1053/j.semtcvs.2018.11.008 DOI: https://doi.org/10.1053/j.semtcvs.2018.11.008
  28. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM Jr. Late survival and symptoms after repair of tetralogy of Fallot. Circulation. 1982 Feb;65(2):403–10. doi: https://doi.org/10.1161/01.CIR.65.2.403 DOI: https://doi.org/10.1161/01.CIR.65.2.403
  29. Smith CA, McCracken C, Thomas AS, Spector LG, St Louis JD, Oster ME, et al. Long-term outcomes of tetralogy of Fallot: a study from the pediatric cardiac care consortium. JAMA Cardiol. 2019 Jan;4(1):34–41. doi: https://doi.org/10.1001/jamacardio.2018.4255 DOI: https://doi.org/10.1001/jamacardio.2018.4255
  30. Bassareo PP, Mercuro G. QRS Complex Enlargement as a Predictor of Ventricular Arrhythmias in Patients Affected by Surgically Treated Tetralogy of Fallot: A Comprehensive Literature Review and Historical Overview. ISRN Cardiol. 2013;2013:782508. doi: https://doi.org/10.1155/2013/782508 DOI: https://doi.org/10.1155/2013/782508
  31. Egbe AC, Miranda WR, Mehra N, Ammash NM, Missula VR, Madhavan M, et al. Role of QRS Fragmentation for Risk Stratification in Adults With Tetralogy of Fallot. J Am Heart Assoc. 2018 Dec;7(24):e010274. doi: https://doi.org/10.1161/JAHA.118.010274 DOI: https://doi.org/10.1161/JAHA.118.010274
  32. Dickinson DF. The normal ECG in childhood and adolescence. Heart. 2005 Dec;91(12):1626–30. doi: https://doi.org/10.1136/hrt.2004.057307 DOI: https://doi.org/10.1136/hrt.2004.057307
  33. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J. 2005 Mar;26(5):433–9. doi: https://doi.org/10.1093/eurheartj/ehi091 DOI: https://doi.org/10.1093/eurheartj/ehi091
  34. Geva T, Mulder B, Gauvreau K, Babu-Narayan SV, Wald RM, Hickey K, et al. Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation. 2018 Nov;138(19):2106–15. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.034740 DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.034740
  35. Latus H, Hachmann P, Gummel K, Khalil M, Yerebakan C, Bauer J, et al. Impact of residual right ventricular outflow tract obstruction on biventricular strain and synchrony in patients after repair of tetralogy of Fallot: a cardiac magnetic resonance feature tracking study. Eur J Cardiothorac Surg. 2015 Jul;48(1):83–90. doi: https://doi.org/10.1093/ejcts/ezu396 DOI: https://doi.org/10.1093/ejcts/ezu396
  36. Freling HG, Willems TP, van Melle JP, van Slooten YJ, Bartelds B, Berger RM, et al. Effect of right ventricular outflow tract obstruction on right ventricular volumes and exercise capacity in patients with repaired tetralogy of fallot. Am J Cardiol. 2014 Feb;113(4):719–23. doi: https://doi.org/10.1016/j.amjcard.2013.10.049 DOI: https://doi.org/10.1016/j.amjcard.2013.10.049
  37. van der Hulst AE, Hylkema MG, Vliegen HW, Delgado V, Hazekamp MG, Rijlaarsdam ME, et al. Mild residual pulmonary stenosis in tetralogy of fallot reduces risk of pulmonary valve replacement. Ann Thorac Surg. 2012 Dec;94(6):2077–82. doi: https://doi.org/10.1016/j.athoracsur.2012.06.065 DOI: https://doi.org/10.1016/j.athoracsur.2012.06.065
  38. Frigiola A, Hughes M, Turner M, Taylor A, Marek J, Giardini A, et al. Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement. Circulation. 2013 Oct;128(17):1861–8. doi: https://doi.org/10.1161/CIRCULATIONAHA.113.001600 DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.001600

Most read articles by the same author(s)